4th Quarter - Report

IPOLICY SOLUTIONS for TWIST BIOSCIENCE CORPORATION

Firm
Client
Income
$43,500
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

No bill #: Labor, Health and Human Services, Education and Related Agencies Appropriations bill

LobbyistCovered position, as disclosed
MEGAN ANDERSON BROOKS —
JENNIFER RACHEL LEIB Fellow, Senate Committee on Health, Education, Labor and Pensions
LINDSEY TRISCHLER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Health Issues HCR

S. 2333: Pandemic All Hazards Preparedness Authorization Act H.R.4702/S.2400 - Securing Gene Synthesis Act H.R. 4421: Preparing for All Hazards and Pathogens Reauthorization Act

LobbyistCovered position, as disclosed
MEGAN ANDERSON BROOKS —
JENNIFER RACHEL LEIB Fellow, Senate Committee on Health, Education, Labor and Pensions
LINDSEY TRISCHLER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 4702 (118th), S. 2400 (118th), S. 2333 (118th), H.R. 4421 (118th)

Medical/Disease Research/Clinical Labs MED

FDA proposed rule on LDTs

LobbyistCovered position, as disclosed
MEGAN ANDERSON BROOKS —
JENNIFER RACHEL LEIB Fellow, Senate Committee on Health, Education, Labor, and Pensions
LINDSEY TRISCHLER —

Contacted: Food & Drug Administration (FDA)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.